New eye drop aims to ease pain after Sight-Saving shots
NCT ID NCT05750589
First seen Apr 14, 2026 · Last updated Jun 12, 2026 · Updated 10 times
Summary
This study tests whether a new eye drop called IRX-101 can reduce pain and surface damage to the cornea after anti-VEGF injections for retinal disease. About 240 adults who receive these injections will be randomly assigned to get either IRX-101 or the standard iodine solution before their injection. The goal is to see if IRX-101 makes the procedure more comfortable and gentler on the eye.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
R. Gary Lane, II MD
San Antonio, Texas, 78240, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.